Roundhill GLP-1 & Weight Loss ETF (OZEM US) stock market data APIs
30.1845
0.15(0.5%)
as of March 23, 2026
Try our APIs with
free plan!
Roundhill GLP-1 & Weight Loss ETF Financial Data Overview
Price chart is built with
Anychart
Prev. Close
30.1845
Open
30.3318
High
30.614
Low
29.8502
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Roundhill GLP-1 & Weight Loss ETF data using free add-ons & libraries
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Roundhill GLP-1 & Weight Loss ETF News
New
FDA Clears NVO's Higher Dose of Wegovy: Diversify With These Health ETFs
The FDA recently approved higher-dose version of Novo Nordisk’s NVO obesity drug Wegovy, further expanding the drug giant’s footprint in the rapidly growing and fiercely competitive weight-loss m...
Healthcare ETFs to Watch as Novo Nordisk Tumbles on Poor Sales Outlook
Shares of Danish drugmaker Novo Nordisk NVO suffered a sharp slump of 15% on the bourses on Tuesday, after the company issued a conservative sales outlook that implied a 5-13% decline in 2026 from las...
Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All
GLP-1 injection pen, pills and vial on desk with stock charts behind, signaling weight-loss drug boom. Key Points With the FDA approval of GLP-1 agonists in pill form, the healthcare industry is loo...
The Obesity Pill Rush: Healthcare ETFs to Gain as FDA Nods to Novo Drug
The recent U.S. Food and Drug Administration (FDA) approval of Novo Nordisk’s NVO oral obesity pill, Wegovy, marks a significant turning point in the fiercely competitive weight-loss drug market. Th...
Get Roundhill GLP-1 & Weight Loss ETF fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
